Nongenomic oestrogen signalling in oestrogen receptor negative breast cancer cells: a role for the angiotensin II receptor AT1

Morley P, Whitfield JF, Vanderhyden BC, Tsang BK, Schwartz JL: A new, nongenomics estrogen action: the rapid release of intracellular calcium. Endocrinology. 1992, 131: 1305-1312. 10.1210/en.131.3.1305.

Audy MC, Vacher P, Duly B: 17β-estradiol stimulates a rapid Ca2+ influx in LNCaP human prostate cancer cells. Eur J Endocrinol. 1996, 135: 367-373.

Improta-Brears T, Whorton AR, Codazzi F, York JD, Meyer T, McDonnell DP: Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. Proc Natl Acad Sci USA. 1999, 96: 4686-4691. 10.1073/pnas.96.8.4686.

Nakhla AM, Khan MS, Rosner W: Biologically active steroids activate receptor-bound human sex hormone-binding globulin to cause LNCaP cells to accumulate adenosine 3', 5'-monophosphate. J Clin Endocrinol Metab. 1990, 71: 398-404.

Aronica SM, Kraus WL, Katzenellenbogan BS: Estrogen action via the cAMP signalling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc Natl Acad Sci USA. 1994, 91: 8517-8521. 10.1073/pnas.91.18.8517.

Le Mallay V, Grosse B, Lieberherr M: Phospholipase C beta and membrane action of calcitriol and estradiol. J Biol Chem. 1997, 272: 11902-11907. 10.1074/jbc.272.18.11902.

Migliaccio A, Di Domenico M, Castoria G, de Falco P, Bontempo P, Nola E, Auricchio F: Tyrosine kinase/p21ras/MAP kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J. 1996, 15: 1292-1300.

Endoh H, Sasaki H, Maruyama K, Takeyama K, Waga I, Shimizu T, Kato S, Kawashima H: Rapid activation of MAP kinase by estrogen in the bone cell line. Biochem Biophys Res Commun. 1997, 235: 99-102. 10.1006/bbrc.1997.6746.

Watters JJ, Campbell JS, Cunningham MJ, Krebs EG, Dorsa EM: Rapid membrane effects of steroids in neuroblastoma cells: effects of estrogen on mitogen-activated protein kinase signalling cascade and c-fos immediate early gene transcription. Endocrinology. 1997, 138: 4030-4033. 10.1210/en.138.9.4030.

Chambliss KL, Yuhanna IS, Mineo C, Liu P, German Z, Sherman TS, Mendelsohn ME, Anderson RG, Shaul PW: Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signalling module in caveolae. Circ Res. 2000, 87: E44-E52.

Haynes MP, Sinha D, Russell KS, Collinge M, Fulton D, Morales-Ruiz M, Sessa WC, Bender JR: Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-AKT pathway in human endothelial cells. Circ Res. 2000, 87: 677-682.

Martin MB, Franke TF, Stoica GE, Chambon P, Katzenellenbogen BS, Stoica BS, McLemore MS, Olivo SE, Stoica A: A role for AKT in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I. Endocrinology. 2000, 141: 4503-4511. 10.1210/en.141.12.4503.

Levin ER: Cellular functions of the plasma membrane estrogen receptor. Trends Endocrinol Metab. 1999, 10: 374-377. 10.1016/S1043-2760(99)00192-7.

Kim HP, Lee JY, Jeong JK, Bae SW, Lee HK, Jo I: Non-genomic stimulation of nitric oxide release by estrogen is mediated by ER-alpha localised in caveolae. Biochem Biophys Res Commun. 1999, 263: 257-263. 10.1006/bbrc.1999.1348.

Razandi M, Oh P, Pedram A, Schnitzer J, Levin ER: Estrogen receptors associated with and regulate the production of caveolin: Implications for signalling and cellular actions. Mol Endocrinol. 2002, 16: 100-115. 10.1210/me.16.1.100.

Razandi M, Pedram A, Greene GL, Levin ER: Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ER-alpha and ER-beta expressed in Chinese hamster ovary cells. Mol Endocrinol. 1999, 13: 307-319. 10.1210/me.13.2.307.

Levin ER: Integration of the extranuclear and nuclear actions of estrogen. Mol Endocrinol. 2005, 19: 1951-1959. 10.1210/me.2004-0390.

Evinger AJ, Levin ER: Requirements for ER-alpha membrane localisation and function. Steroids. 2005, 70: 361-368. 10.1016/j.steroids.2005.02.015.

Razandi M, Pedram A, Merchenthaler I, Greene GL, Levin ER: Plasma membrane estrogen receptors exist and function as dimmers. Mol Endocrinol. 2004, 18: 2854-2865. 10.1210/me.2004-0115.

Chambliss KL, Simon L, Yuhanna IS, Mineo C, Shaul PW: Dissecting the basis of nongenomic activation of eNOS by estradiol: Role of ER-alpha domains with known nuclear functions. Mol Endocrinol. 2005, 19: 277-289. 10.1210/me.2004-0008.

Filardo EJ, Quinn JA, Bland KI, Frackelton AR: Estrogen induced activation of Erk-1 and Erk-2 requires the G-protein-coupled receptor homolog, GPR30, and occurs via transactivation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol. 2000, 14: 1649-1660. 10.1210/me.14.10.1649.

Maggiolini M, Vivaeaqua A, Fasanella G, Recchia AG, Sisci D, Pezzi V, Mantanaro D, Musti AM, Picard D, Ando S: The G protein-coupled receptor GPR30 mediates c-Fos up-regulation by both 17-beta-estradiol and phytoestrogens in breast cancer cells. J Biol Chem. 2004, 279: 27008-27016. 10.1074/jbc.M403588200.

Filardo EJ, Quinn JA, Frackelton AR, Bland KI: Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signalling axis. Mol Endocrinol. 2002, 16: 70-84. 10.1210/me.16.1.70.

Inwang ER, Puddefoot JR, Brown CL, Goode AW, Marsigliante S, Ho MM, Payne JG, Vinson GP: Angiotensin II type 1 receptor expression in human breast tissues. Br J Cancer. 1997, 75: 1279-1283.

Schieffer B, Paxton WG, Marrero MB, Bernstein KE: Importance of tyrosine phosphorylation in angiotensin II type 1 receptor signalling. Hypertension. 1996, 27: 476-480.

Marrero MB, Schieffer B, Paxton WG, Heerdt L, Berk BC, Delafontaine P, Bernstein KE: Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature. 1995, 375: 247-250. 10.1038/375247a0.

Greco S, Muscella A, Elia MG, Salvatore P, Storelli C, Mazzotta A, Manca C, Marsigliante S: Angiotensin II activates extracellular signal regulated kinases via protein kinase C and epidermal growth factor receptor in breast cancer cells. J Cell Physiol. 2003, 196: 370-377. 10.1002/jcp.10313.

Myers E, Fleming JF, Crotty TB, Kelly G, McDermott EW, O'Higgins NJ, Hill AD, Young LS: Inverse relationship between ER-beta and SRC-1 predicts outcome in endocrine resistant breast cancer. Br J Cancer. 2004, 91: 1687-1693.

Razandi M, Pedram A, Park ST, Levin ER: Proximal events in signalling by plasma membrane estrogen receptors. J Biol Chem. 2003, 278: 2701-2712. 10.1074/jbc.M205692200.

Filardo EJ: Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signalling pathway with potential significance for breast cancer. J Steroid Biochem Mol Biol. 2002, 80: 231-238. 10.1016/S0960-0760(01)00190-X.

Piiper A, Gebhardt R, Kronenberger D, Giannini C, Elez R, Zeuzem S: Pertussis toxin inhibits cholecystokinin-and epidermal growth factor induced mitogen activated protein kinase activation by disinhibition of the cAMP signalling pathway and inhibition of c-Raf-1. Mol Pharmacol. 2000, 58: 608-613.

Melien O, Sandnes D, Johansen J, Christoffersen T: Effects of pertussis toxin on extracellular signal regulated kinase activation in hepatocytes by hormones and receptor-independent agents: evidencesuggesting a stimulatory role of Gi proteins at a level distal to receptor coupling. J Cell Physiol. 2000, 184: 27-36. 10.1002/(SICI)1097-4652(200007)184:1<27::AID-JCP3>3.0.CO;2-Q.

Smith RD, Baukal AJ, Dent P, Catlk J: Raf-1 kinase activation by angiotensisn II in adrenal glomerulosa cells: roles for Gi, phosphalidylinositol 3-kinase and Ca2+ influx. Endocrinology. 1999, 140: 1385-1391. 10.1210/en.140.3.1385.